Providence cancer spinoff charges ahead with immunotheapy drugs

Since Agonox did a deal with an AstraZeneca, the company has moved into new areas of research.

Source: bizjournals.com Health Care:Biotechnology headlines - September 5, 2018 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news